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Host responses to cytomegalovirus infection include initial early production of a and b interferons, also called
type I interferons, which are elicited directly by viral products via Toll-like receptors. New data indicate that,
preceding these events, an earlier critical type I interferon elicited in primary infected stromal cells via the lym-
photoxin b receptor system andmediated by B cells is necessary to kick-start an efficient antiviral response.Infection with human cytomegalovirus
(HCMV) can cause life-threatening dis-
ease in immunodeficient hosts, but it is
rarely symptomatic in immune-compe-
tent individuals. The experimental model
of mouse cytomegalovirus (MCMV) infec-
tion has contributed greatly to our under-
standing of the molecular determinants of
pathogenesis. As a first line of defense
against MCMV infection, the type I inter-
feron (IFNab) response stimulates natural
killer (NK) and T cells that are critical at
later time points of infection (Garcia-
Sastre and Biron, 2006). This occurs
through Toll-like receptors (TLR), a class
of membrane receptors that sense patho-
gen-associated molecular patterns either
in the extracellular or intracellular milieu.
Engagement of specific TLR receptors
initiates a molecular signaling cascade
that leads to the activation of gene tran-
scription factors, including IFN-regulated
factors and NF-kB. This cascade ulti-
mately leads to the production of IFNab
and to the control of infection. Previously,
the earliest known consequence of this
cascade involved dendritic cells, which
express TLR and by 48 hr postinfection
(after the completion of the first round of
viral spread) produce large amount of
IFNab (Delale et al., 2005).
There is, however, a second critical
pathway for the control of MCMV infec-
tion: the lymphotoxin b receptor (LTbR)
(Banks et al., 2005) belonging to the sys-
tem of the tumor necrosis factor (TNF)
superfamily (Ware, 2005). LtbR binds
to a membrane-bound heterodimer of
lymphotoxin (LT) a and b. LTab is ex-
pressed in activated T and B lymphocytes
and NK cells, whereas LTbR expression isrestricted to stromal and myeloid cells.
LTbR signaling also leads to the activation
of NF-kB and type I IFN secretion (Basak
et al., 2007). Several lines of evidence in-
dicate that the pathway is physiologically
significant for resistance to MCMV inde-
pendently of the defect in the secondary
lymphoid organogenesis observed in LT-
deficient mice. The LTbR axis protective
against MCMV infection is also associ-
ated with a phase of type I IFN that is eli-
cited as early as 8 hr postinfection. This
response is thought to put in motion the
multiple layers of host defenses against
MCMV (Banks et al., 2005). In this issue
of Cell Host & Microbe, Schneider et al.
(2008) describe captivating studies in
mice that provide a fresh view of this initial
type I IFN response against MCMV. More
precisely, the study indicates that the
LTbR-IFN axis is a frontline effector of
MCMV control independent of TLR recep-
tors. The authors define the requirement
of LT-competent B cells and LTbR-com-
petent stromal cells, which are both re-
quired in order for the type I IFN response
to occur, as illustrated in Figure 1.
An important aspect of the present
study is the demonstration that many
mouse strains carrying a variety of single,
double, or conditionally manipulated ge-
netic changes can be exploited for the
systematic dissection of cell-cell or cell-
pathogen interactions in a system as
complex as LTbR. Thus, to allow a closer
examination of the initial stages of the
IFN response, Schneider et al. (2008) use
as many as 17 different mouse strains to
dissect functional redundancy through
the numerous systems that are dependent
on the LTbR pathway. In these models,Cell Host & Microbvirus transcripts and IFN responses are
simply measured at the transcriptional
level in the spleen (a primary target organ
of MCMV), and in serum proteins at 8 hr
postinfection.
First, using targeted mutants,
Schneider et al. (2008) show that the early
IFN response is attenuated in LTb/LIGHT
(another ligand to LTb)-deficient mice
and that at least the IFNb component of
the response can be restored with the
administration of anti-LTbR agonist anti-
bodies. Using different infectious doses
and monitoring virus transcripts, they
observe that IFN secretion is dependent
on the amount of inoculum. This result
indicated that the response is elicited
by a titrable factor that directly ‘‘senses’’
virus replication in the primary infected
cells before the first round of virus replica-
tion. Furthermore, the study suggests that
TLRs—the obvious candidates—are not
involved in sensing this process. Neither
a gene deficit in TLR9, the adaptor TRIF,
nor double knockout mice with mutations
in TRIF and the adaptor MyD88 lacking
signaling response through all TLR ago-
nists affected the early IFN response.
This is remarkable becauseprevious stud-
ies showed that mutations in genes that
encode components of the TLR pathway
(TLR9, TLR3, UNC93B, MYD88) are asso-
ciated with the lack of type I IFN response
and severe susceptibility to MCMV
(Beutler et al., 2007). LTbR is more widely
expressed in different cell types constitut-
ing the spleen stroma such as follicular
cells, epithelial cells, and endothelial cells.
These cells are also thought to be primar-
ily infected. Schneider et al. conclude
from these results that the LTbR pathwaye 3, February 2008 ª2008 Elsevier Inc. 59
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MCMV independently of TLRs. This im-
plies that, without input from the LTbR
signaling axis, the normal TLR-sensing
apparatus of wild-typemice is inadequate
to contain an MCMV infection.
Another advantage of genetically ma-
nipulated mice is that one can test cellular
functions in vivo. Therefore, to determine
the cellular source of LTb, Schneider
et al. (2008) used MCMV infection of
a large panel of targeted mutant mice in
lymphocytes and lymphocyte subsets,
as well as mice with the LTb gene specif-
ically ablated in T or B cell populations.
Consistently, mice lacking either B cells,
or the expression of the LTb gene in
B cells displayed a drastic reduction in
the initial type I IFN response. From this
data, Schneider et al. deduced that LTb
expressed in B cells delivers a critical sig-
nal that elicits the initial IFN response. This
brings B cells to the forefront to play a pre-
viously unknown role as the mediators of
the initial IFN response against MCMV.
Earlier reports established that, in addi-
tion to elements of the innate immune sys-
tem, both cellular and humoral responses
of the adaptive immunity are important
in the control of MCMV infection. B cell-60 Cell Host & Microbe 3, February 2008 ª20derived antibodies are important in pro-
tecting against a primary infection as
well as reactivation or reinfection (Jonjic
et al., 1994). More recently, the adoptive
transfer of memory B cells to immunode-
ficient RAG/ (recombination-activating
gene) mice has shown to protect against
lethal MCMV infection. These mice se-
creted MCMV-specific immunoglobulin
G (IgG), suggesting that newly produced
antibodies make up this protective mech-
anism (Klenovsek et al., 2007). In contrast,
the early role of B cells in the course of
a MCMV infection has not been analyzed
in detail. The early function identified by
Schneider et al. of a cell compartment as-
cribed to the adaptive immune response
is unexpected and further blurs the defini-
tions of innate and adaptive immunity.
Naive B cells deliver the LTb signal but
do not express LTbR. Therefore, the
next logical step was to identify the cell
compartment requiring LTbR expression.
Using bone marrow transplantation ex-
periments, Schneider et al. (2008) show
that irradiated wild-type mice receiving
LTbR/ bone marrow produced normal
levels of IFN. In contrast, LTbR/ recipi-
ent mice reconstituted with wild-type
bone marrow exhibited reduced IFN08 Elsevier Inc.accumulation. Using different spleen cell
fractions, the authors go on to show that
only isolated stromal cells from infected
mice secrete IFNs. Finally, when the sim-
ilar experiments are performed with mice
deficient in NF-kB-inducing kinase (NIK),
the stromal compartment shows reduced
IFN amounts. NIK kinase is part of the
noncanonical NF-kB pathway activated
by LTbR (Basak et al., 2007), which is in-
volved in lymphoid organ development
aswell as in the innate response to viral in-
fection. Based on their results, Schneider
et al. (2008) conclude that the relevant
LTbR signaling in this system resides in
the radio-resistant compartment and
isolated stromal cells.
In summary, Schneider et al. conclude
that the LTbR-IFN axis is a frontline effec-
tor of MCMV control. This is truly exciting.
Their work also raises a number of inter-
esting questions. First of all, the molecular
link between MCMV and LTbR-elicited
IFN remains to be characterized. Part of
the answer may come from identifying
the viral or virally induced mechanism
necessary for the initial type I IFN secre-
tion. Lately, the list of sensors of viral nu-
cleic acids has been extended with the
identification of cytosolic receptors that
recognize DNA in a particular conforma-
tion (Pichlmair and Reis e Sousa, 2007).
The possibility exists that MCMV is de-
tected by ‘‘sensors’’ in the primary in-
fected cells. Second, the mechanism
that promotes B cells to deliver the LTb
signal is still unknown. B cells are not pro-
ductively infected, therefore it will be im-
portant to characterize the cell-specific
expression of LTb during infection. Third,
while the signaling pathway through
LTbR involves NIK, the specific role of
this kinase in the context of virus infection
deserves closer examination.
Another important question is whether
mice and humans share a conserved
LT-IFNb axis. Notably, an additional strat-
egy involving LTbR-dependent induction
of IFNb was revealed from an investiga-
tion of HCMV. This pathway requires both
cytokine signaling and virus replication
to induce IFNb mRNA. HCMV blocks the
induction of IFNb in infected cells, yet sig-
naling by LT-related ligands through LTbR
circumvented this virus-imposed block
on IFNb induction (Benedict et al., 2001).
Genes encoding host evasion products
are not well conserved between HCMV
and MCMV. Nevertheless, there areFigure 1. LTab Expressed on Splenic B Cells Engages Stromal LTb Cell Receptor and
Initiates Activation of Type I IFN Genes
(Right) In the white pulp spleen microenvironment, at early stages, stromal cells (including fibroblasts, en-
dothelial cells, and follicular cells) are infected by MCMV. These cell types express LTbR, which interacts
with its cognate ligand, LTb, on B cells and promotes the expression of IFNb by stromal cells. (Left) The
interaction between LTb and LTbR leads to the activation of the type I interferon pathways. The NK-kB
noncanonical pathway involving the NIK and IKKa kinases is stimulated through LTb- and LTbR-specific
interaction, which activates and processes the NF-kB complex, which finally binds to the DNA into the
nucleus, eliciting IFNb gene transcription.
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elicited upon infection of cells by both
viruses, indicating that LTbR may operate
similarly against both viruses.
Identifying the underlyingmolecular and
cellular mechanisms of host response to
MCMV is not only of scientific interest
but also of medical relevance. High type I
interferon levels are deleterious in autoim-
mune diseases. Therefore, manipulation
of the LTbR pathway has been pursued
as a possible treatment. Inhibition of the
LT pathway stops the development of col-
lagenase-induced arthritis and protects
adult animals against experimental auto-
immune encephalomyelitis (EAE) (Ware,
2005). The study of Schneider et al.
(2008) indicates that regulation of the
type I IFN through LT signaling may also
represent an alternative therapeutic strat-
egy in cases of severe HCMV infection.Deploying Parasite
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The phylum Apicomplexa is composed of
unicellular eukaryotes that live as intracel-
lular parasites. Many cause acute disease
and death in humans as well as impact-
ing the livestock industry throughout the
world. However, one such apicomplexan,
Toxoplasma gondii, while extremely com-
mon (between 20% and 80% of humans
worldwide harbor the parasite), normally
causes asymptomatic infection. Yet, true
to form for an opportunistic pathogen,
Toxoplasma can cause serious trouble inACKNOWLEDGMENTS
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In the laboratory, Toxoplasma has be-
come a favorite model pathogen of cell
biologists and immunologists alike. Cell
biologists have come far in unraveling
the molecular machinery the parasite
uses to invade and live within the host
cell. This effort has been tremendously
helped by sequencing of the Toxoplasma
genome, and the development of a so-
phisticated toolbox of forward and re-
verse genetic techniques. Immunologists
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know T. gondii as a prototypic Th1-in-
ducing pathogen, at the center of which
is the parasite’s ability to induce the cy-
tokine interleukin-12 (IL-12). In this issue
of Cell Host & Microbe, Plattner and
colleagues provide a striking example
of how tools of molecular biology can
be skillfully wielded to unite immunology
and cell biology, providing insight into
a parasite molecule that seems to be
prominent in the infection biology of
T. gondii (Figure 1).
e 3, February 2008 ª2008 Elsevier Inc. 61
